Michael Barbella, Managing Editor05.25.24
Materials and motion preservation were reader darlings this past week on the ODT website.
A magazine feature (May/June issue) on the orthobiologics market took top billing, while a column about the regulatory challenges for magnesium-based orthopedic products placed third. The latter piece, also appearing in the magazine's current issue, revealed the regulatory challenges as in-vitro degradation profile, hydrogen evolution, in vivo degredation profile, corrosion under mechanical testing, biocompatibility, and chemical characterization.
Following close behind the materials movement was motion preservation—in particular an online exclusive that explores the attributes, market dynamics, and predicted future of vertebral body tethering in the spinal care market.
New personnel and products made the cut as well this past week. Bioretec drove traffic with word of its new CEO Alan Donze, whose storied career has included stints with Chase bank, Stryker Corp., Smith+Nephew, Bioventus, Lima Corporate, Isotis Orthobiologics, Aerobiotix, and Rx.Health.
Shoulder Innovations drove considerable traffic too by launching its InSet 95 humeral stem. The product, according to the company, enhances surgical outcomes and improves recovery for those with poor bone quality. InSet 95 has a unique two-fin design engineered for rotational control and stability. This allows precise implant alignment, which is crucial for optimal biomechanics in shoulder replacement surgery. Its proximal design has the same inlay humeral design characteristics of the InSet short stem and stemless implants.
A magazine feature (May/June issue) on the orthobiologics market took top billing, while a column about the regulatory challenges for magnesium-based orthopedic products placed third. The latter piece, also appearing in the magazine's current issue, revealed the regulatory challenges as in-vitro degradation profile, hydrogen evolution, in vivo degredation profile, corrosion under mechanical testing, biocompatibility, and chemical characterization.
Following close behind the materials movement was motion preservation—in particular an online exclusive that explores the attributes, market dynamics, and predicted future of vertebral body tethering in the spinal care market.
New personnel and products made the cut as well this past week. Bioretec drove traffic with word of its new CEO Alan Donze, whose storied career has included stints with Chase bank, Stryker Corp., Smith+Nephew, Bioventus, Lima Corporate, Isotis Orthobiologics, Aerobiotix, and Rx.Health.
Shoulder Innovations drove considerable traffic too by launching its InSet 95 humeral stem. The product, according to the company, enhances surgical outcomes and improves recovery for those with poor bone quality. InSet 95 has a unique two-fin design engineered for rotational control and stability. This allows precise implant alignment, which is crucial for optimal biomechanics in shoulder replacement surgery. Its proximal design has the same inlay humeral design characteristics of the InSet short stem and stemless implants.